CN101897754A - Polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation and preparation method thereof - Google Patents
Polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation and preparation method thereof Download PDFInfo
- Publication number
- CN101897754A CN101897754A CN2010102213061A CN201010221306A CN101897754A CN 101897754 A CN101897754 A CN 101897754A CN 2010102213061 A CN2010102213061 A CN 2010102213061A CN 201010221306 A CN201010221306 A CN 201010221306A CN 101897754 A CN101897754 A CN 101897754A
- Authority
- CN
- China
- Prior art keywords
- injection
- radix salviae
- salviae miltiorrhizae
- polyethyleneglycol
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention discloses a polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation and a preparation method thereof. The danshen root medicament injection preparation is an injectable medicament mainly prepared by dissolving a danshen root extract and the polyethylene glycol 12-hydroxy stearate which is used for improving the clarity of the injection in water for injection; and the dosage of the polyethylene glycol 12-hydroxy stearate is 0.1 to 1.0 g/100 ml. In the danshen root medicament injection preparation, the polyethylene glycol 12-hydroxy stearate with a certain concentration is used to make an active component, namely a traditional Chinese medicine extract obtain the maximum solubility, and simultaneously improve the clarity of the injection, so that the problems of easy sedimentation, turbidness and the like of the danshen root injection during storage and high-temperature sterilization are satisfactorily solved.
Description
Technical field
The present invention particularly, relates to a kind of Radix Salviae Miltiorrhizae medicine ejection preparation that contains polyethyleneglycol-12-hydroxy stearin and preparation method thereof in medical technical field.
Background technology
The Radix Salviae Miltiorrhizae Injection standard is recorded in health drug standard promulgated by the ministries or commissions of the Central Government (WS3-B-3766-98, the 20th in Chinese traditional patent formulation preparation), is the sterile water solution of extract through being processed into by red rooted salvia.Get Radix Salviae Miltiorrhizae 1500g, decoct with water three times, 2 hours for the first time, second and third time each 1.5 hours, collecting decoction filters, and filtrate decompression is concentrated into 750ml.Add the ethanol precipitation secondary, make for the first time that to contain the alcohol amount be 75%, make that to contain the alcohol amount be 85% for the second time, each all cold preservation is placed the back and is filtered, filtrate recycling ethanol, and be concentrated into about 250ml, add the injection water to 400ml, mixing, cold preservation is placed, filter, regulate pH value to 6.8, boil half an hour with 10% sodium hydroxide solution, filter, add the injection water to 1000ml, embedding, sterilization, promptly.
Radix Salviae Miltiorrhizae Injection has blood circulation promoting and blood stasis dispelling, the effect of freeing vessels and nourishing heart.Clinical to be used for coronary heart disease uncomfortable in chest, angina pectoris.Usage and dosage is intramuscular injection, a 2～4ml, 1～2 time on the one; Intravenous injection, a 4ml (using), 1～2 time on the one with 50% glucose injection 20ml dilution back; Intravenous drip, a 10～20ml (using), 1 time on the one with 5% glucose injection, 100～500ml dilution back.Or follow the doctor's advice.
The main component Radix Salviae Miltiorrhizae extract that obtains according to Radix Salviae Miltiorrhizae Injection quality standard method for making contains ester soluble components such as TANSHINONES not soluble in water, causes Radix Salviae Miltiorrhizae Injection to be prone to problems such as precipitation, solution muddiness in storage and high temperature sterilize process.At present, use polyoxyethylene sorbitan monoleate as cosolvent in the Radix Salviae Miltiorrhizae Injection, but polyoxyethylene sorbitan monoleate becomes sour in storage and high temperature sterilize process easily, cause the impurity content height, easily and ingredient generation chemical change, product still has the problem of small amount of precipitate, solution muddiness to occur in storage process, causes the visible foreign matters inspection of product not meet the regulation of drug standard, makes troubles for clinical application and popularization.
Patent documentation 200710143306.2 discloses a kind of preparation method of Radix Salviae Miltiorrhizae Injection and the micelle ultrafiltration of bibliographical information prepares Radix Salviae Miltiorrhizae Injection (wangdan etc., the 25th the 6th phase of volume of Chinese patent medicine), mainly the macromole impurity of being removed in the medicinal liquid by the extracting solution employing ultrafiltration of 1500 parts of Radix Salviae Miltiorrhizaes (as tannin, protein) is made, precipitate in put procedure to solve Radix Salviae Miltiorrhizae Injection, problem such as muddiness, wherein literature method also adds tween 80 and makes cosolvent in medicinal liquid.Because of the TANSHINONES water solublity in this product principal agent composition very poor, and tween 80 has stronger hemolytic and anaphylaxis, so problems such as the solution Radix Salviae Miltiorrhizae Injection that adopts above method acquisition injection still can not be satisfied with precipitates in put procedure, muddiness can't satisfy the clinical practice needs.
Summary of the invention
Technical problem to be solved by this invention provides a kind of Radix Salviae Miltiorrhizae medicine ejection preparation that contains polyethyleneglycol-12-hydroxy stearin and preparation method thereof, it could be that Chinese medicine extract is obtaining to improve clarity of injection in the maxima solubility making active component that this Radix Salviae Miltiorrhizae medicine ejection preparation uses certain density polyethyleneglycol-12-hydroxy stearin, solves Radix Salviae Miltiorrhizae Injection satisfactorily and be prone to problems such as precipitation, muddiness in storage and high temperature sterilize process.
The present invention addresses the above problem the technical scheme that is adopted: a kind of polyethyleneglycol-12-hydroxy stearin (Solutol HS-that contains
) Radix Salviae Miltiorrhizae medicine ejection preparation, mainly by Radix Salviae Miltiorrhizae extract and the polyethyleneglycol-12-hydroxy stearin that is used to improve clarity of injection be dissolved in the injection medicine that water for injection is made, the consumption of described polyethyleneglycol-12-hydroxy stearin is 0.1g～1.0g/100ml.
Particularly, the consumption of polyethyleneglycol-12-hydroxy stearin is the arbitrary value among 0.1g～1.0g/100ml, based on obtain solution cumulative volume meter, as 0.1g/100ml, 0.2g/100ml, 0.5g/100ml, 1.0g/100ml etc.; Preferable amount is 0.2g-0.5g/100ml.
In the above-mentioned Radix Salviae Miltiorrhizae medicine ejection preparation, the consumption of Radix Salviae Miltiorrhizae extract can be that every 100ml solution contains and is equivalent to the 100g-200g red rooted salvia and extracts Radix Salviae Miltiorrhizae extract with the process for refining preparation according to injection.
Described Radix Salviae Miltiorrhizae medicine ejection preparation dosage form can be made pharmaceutically acceptable regular dosage forms such as injection, freeze-dried powder.
A kind of above-mentioned preparation method that contains the Radix Salviae Miltiorrhizae medicine ejection preparation of polyethyleneglycol-12-hydroxy stearin comprises the steps:
(1) gets raw medicinal material Radix Salviae Miltiorrhizae 1000～2000 weight portions; Polyethyleneglycol-12-hydroxy stearin 1.0～10.0 weight portions;
(2) red rooted salvia extracts the Radix Salviae Miltiorrhizae extract for preparing with process for refining according to injection, adds polyethyleneglycol-12-hydroxy stearin and water for injection and is mixed with 1000ml solution;
(3) regulator solution pH value to 5.0～9.0, solution filters through microporous filter membrane; Fill, sterilization, promptly.
Perhaps
(1) gets raw medicinal material Radix Salviae Miltiorrhizae 1000-2000 weight portion; Solutol HS-
1.0-10.0 weight portion;
(2) Radix Salviae Miltiorrhizae decocts with water three times, and 2 hours for the first time, second and third time each 1.5 hours, collecting decoction filters, and filtrate decompression is concentrated into 750ml.Add the ethanol precipitation secondary, make for the first time that to contain the alcohol amount be 75%, make that to contain the alcohol amount be 85% for the second time, each all cold preservation is placed the back and is filtered, filtrate recycling ethanol, and be concentrated into about 250ml, add the injection water to 400ml, mixing, cold preservation is placed, filter, regulate pH value to 6.8, boil half an hour with 10% sodium hydroxide solution, filter, filtrate adds the Polyethylene Glycol 12-hydroxy stearic acid ester, and adds the injection water to 1000ml, stirs evenly.
(3) regulate pH value to 6.8 with 10% sodium hydroxide solution, filter, embedding, sterilization, promptly.
In step (2) and step (3), further optimize as follows:
(2) Radix Salviae Miltiorrhizae decocts with water three times, and 2 hours for the first time, second and third time each 1.5 hours, collecting decoction filters, and filtrate decompression is concentrated into 750ml.Add the ethanol precipitation secondary, make for the first time that to contain the alcohol amount be 75%, make that to contain the alcohol amount be 85% for the second time, each all cold preservation is placed the back and is filtered, filtrate recycling ethanol, and be concentrated into about 250ml, add the injection water to 400ml, mixing, cold preservation is placed, filter, regulate pH value to 6.8, boil half an hour with 10% sodium hydroxide solution, filter, filtrate adds the Polyethylene Glycol 12-hydroxy stearic acid ester, and adds the injection water to 1000ml, stirs evenly.
(3) regulate pH value to 6.8 with 10% sodium hydroxide solution, filter, embedding, sterilization, promptly.
The present invention discovers by experiment, at a kind of above-mentioned polyethyleneglycol-12-hydroxy stearin (Solutol HS-that contains
) Radix Salviae Miltiorrhizae medicine ejection preparation in, polyethyleneglycol-12-hydroxy stearin (SolutolHS-
) consumption the Radix Salviae Miltiorrhizae Injection composition is had good solute effect when being 0.1g～1.0g/100ml, and prove by concrete experimental data hereinafter, and preferable amount cost is relatively low when being 0.2g～0.5g/100ml, product quality is better, safety is higher relatively.Polyethyleneglycol-12-hydroxy stearin (SolutolHS-
) recorded in European Pharmacopoeia (EP5.5), Deutscher Arzneibucs and British Pharmacopoeia, can be used for the solubilizing agent of ejection preparation.
In sum, the invention has the beneficial effects as follows: the present invention discovers by experiment, is containing polyethyleneglycol-12-hydroxy stearin (Solutol HS-
) Radix Salviae Miltiorrhizae medicine ejection preparation in, polyethyleneglycol-12-hydroxy stearin (Solutol HS-
) consumption can be stable in high temperature and storage process when being 0.1g～1.0g/100ml the visible foreign matters of maintenance injection detect the regulation that meets drug standard, improve the clarity of Radix Salviae Miltiorrhizae medicine ejection preparation, solved becoming sour easily that the existing cosolvent of Radix Salviae Miltiorrhizae medicine ejection preparation employing occurs in storage and high temperature sterilize process, cause the impurity content height, easily and ingredient generation chemical change, product still has a small amount of small particles in storage process, white piece, the problem of solution muddiness occurs, can guarantee that the visible foreign matters inspection of product meets the regulation of drug standard, is convenient to clinical application and popularization.
Description of drawings
Fig. 1 is the solubilization-aid effect sketch map of variable concentrations polyethyleneglycol-12-hydroxy stearin to Radix Salviae Miltiorrhizae medicine ejection preparation.
The specific embodiment
The present invention is described in further detail below in conjunction with embodiment, but embodiments of the present invention are not limited thereto.
A kind of Radix Salviae Miltiorrhizae medicine ejection preparation that contains polyethyleneglycol-12-hydroxy stearin, mainly by Radix Salviae Miltiorrhizae extract and the polyethyleneglycol-12-hydroxy stearin that is used to improve clarity of injection be dissolved in the injection medicine that water for injection is made, the consumption of described polyethyleneglycol-12-hydroxy stearin is 0.1g～1.0g/100ml.
The concrete preparation method of present embodiment is as follows:
Radix Salviae Miltiorrhizae 1500g
Solutol?HS-
2.0g
Radix Salviae Miltiorrhizae decocts with water three times, and 2 hours for the first time, second and third time each 1.5 hours, collecting decoction filters, and filtrate decompression is concentrated into 750ml.Add the ethanol precipitation secondary, make for the first time that to contain the alcohol amount be 75%, make that to contain the alcohol amount be 85% for the second time, each all cold preservation is placed the back and is filtered, filtrate recycling ethanol, and be concentrated into about 250ml, add the injection water to 400ml, mixing, cold preservation is placed, and filters, and regulates pH value to 6.8 with 10% sodium hydroxide solution, boil half an hour, filter, filtrate adds the Polyethylene Glycol 12-hydroxy stearic acid ester, and adds the injection water to 1000ml, stir evenly, regulate pH value to 6.8 with 10% sodium hydroxide solution, filter embedding, sterilization, promptly.
Radix Salviae Miltiorrhizae 1000-2000g
Solutol?HS-
1.0-10.0g
Radix Salviae Miltiorrhizae decocts with water three times, and 2 hours for the first time, second and third time each 1.5 hours, collecting decoction filters, and filtrate decompression is concentrated into 750ml.Add the ethanol precipitation secondary, make for the first time that to contain the alcohol amount be 75%, make that to contain the alcohol amount be 85% for the second time, each all cold preservation is placed the back and is filtered, filtrate recycling ethanol, and be concentrated into about 250ml, add the injection water to 400ml, mixing, cold preservation is placed, and filters, and regulates pH value to 6.8 with 10% sodium hydroxide solution, boil half an hour, filter, filtrate adds the Polyethylene Glycol 12-hydroxy stearic acid ester, and adds the injection water and be mixed with certain density solution, stir evenly, regulate pH value to 6.8 with 10% sodium hydroxide solution, filter packing, freeze-dried powder is made in lyophilization, promptly.
Embodiment 3
Polyoxyethylene sorbitan monoleate and Solutol HS-
The Radix Salviae Miltiorrhizae Injection stability comparative test of solubilising
Utilize the stability of solution of the prepared Radix Salviae Miltiorrhizae Injection of the present invention fine, solved Radix Salviae Miltiorrhizae Injection and in storage and high temperature sterilize process, be prone to problems such as precipitation, solution muddiness.Utilize the related request of the prepared Radix Salviae Miltiorrhizae Injection of the present invention according to two appendix XI of Chinese Pharmacopoeia version in 2005 X C pharmaceutical preparation stability test guideline, investigated respectively at 25 ℃ and placed 6 months, 60 ℃ medicine stabilities of placing 20 days of 36 months, 40 ℃ placements, the result is constant product quality under above-mentioned experimental condition, and each detects the regulation that index meets this product quality standard.
The pharmacological results shows: utilize the prepared Radix Salviae Miltiorrhizae Injection of the present invention not have hemolytic, no anaphylaxis, nonirritant, meet the requirement of drug administration by injection.
Table 1 Radix Salviae Miltiorrhizae Injection contains different amounts Solutol HS-
End product quality is investigated the result
25 ℃ of study on the stability results of table 2
60 ℃ of study on the stability results of table 3
40 ℃ of study on the stability results of table 4
According to The above results as can be known, the polyethyleneglycol-12-hydroxy stearin (SolutolHS-that contains of the present invention
) Radix Salviae Miltiorrhizae medicine ejection preparation under the long situation of period of storage (more than 24 months), can improve the clarity of Radix Salviae Miltiorrhizae medicine ejection preparation, the visible foreign matters of maintenance injection that can be stable detects the regulation that meets drug standard, having solved the problem that injection that Radix Salviae Miltiorrhizae medicine ejection preparation adopts existing cosolvent (tween 80) to occur under the long situation of period of storage has a small amount of small particles, white piece, solution muddiness occurs, can guarantee that the visible foreign matters inspection of product meets the regulation of drug standard, is convenient to clinical application and popularization.
As mentioned above, just can realize the present invention preferably.
Claims (4)
1. Radix Salviae Miltiorrhizae medicine ejection preparation that contains polyethyleneglycol-12-hydroxy stearin, it is characterized in that, mainly by Radix Salviae Miltiorrhizae extract and the polyethyleneglycol-12-hydroxy stearin that is used to improve clarity of injection be dissolved in the injection medicine that water for injection is made, the consumption of described polyethyleneglycol-12-hydroxy stearin is 0.1g～1.0g/100ml.
2. a kind of Radix Salviae Miltiorrhizae medicine ejection preparation that contains polyethyleneglycol-12-hydroxy stearin according to claim 1 is characterized in that the consumption of described polyethyleneglycol-12-hydroxy stearin is 0.2g～0.5g/100ml.
3. a kind of Radix Salviae Miltiorrhizae medicine ejection preparation that contains polyethyleneglycol-12-hydroxy stearin according to claim 1 and 2 is characterized in that described Radix Salviae Miltiorrhizae medicine ejection preparation dosage form is injection or freeze-dried powder.
4. an above-mentioned preparation method that contains the Radix Salviae Miltiorrhizae medicine ejection preparation of polyethyleneglycol-12-hydroxy stearin is characterized in that, comprises the steps:
(1) gets raw medicinal material Radix Salviae Miltiorrhizae 1000～2000 weight portions; Polyethyleneglycol-12-hydroxy stearin 1.0～10.0 weight portions;
(2) red rooted salvia extracts the Radix Salviae Miltiorrhizae extract for preparing with process for refining according to injection, adds polyethyleneglycol-12-hydroxy stearin and water for injection and is mixed with 1000ml solution;
(3) regulator solution pH value to 5.0～9.0, solution filters through microporous filter membrane; Fill, sterilization, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102213061A CN101897754B (en) | 2010-07-08 | 2010-07-08 | Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102213061A CN101897754B (en) | 2010-07-08 | 2010-07-08 | Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013103179076A Division CN103417623A (en) | 2010-07-08 | 2010-07-08 | Salvia miltiorrhiza drug injection preparation containing polyethylene glycol 12 hydroxy stearic acid ester (Solutol HS 15, registered) and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101897754A true CN101897754A (en) | 2010-12-01 |
| CN101897754B CN101897754B (en) | 2013-08-14 |
Family
ID=43223894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102213061A Active CN101897754B (en) | 2010-07-08 | 2010-07-08 | Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101897754B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106111A (en) * | 2015-09-23 | 2015-12-02 | 成都艾比科生物科技有限公司 | Safe medicine composition for compound gastrodin injection and preparation method of safe medicine composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1701808A (en) * | 2005-03-31 | 2005-11-30 | 张文芳 | Emulsion of red sage root for injection and its preparation process |
| CN101518617A (en) * | 2009-04-02 | 2009-09-02 | 四川升和制药有限公司 | Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same |
-
2010
- 2010-07-08 CN CN2010102213061A patent/CN101897754B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1701808A (en) * | 2005-03-31 | 2005-11-30 | 张文芳 | Emulsion of red sage root for injection and its preparation process |
| CN101518617A (en) * | 2009-04-02 | 2009-09-02 | 四川升和制药有限公司 | Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same |
Non-Patent Citations (5)
| Title |
|---|
| 《中国实验方剂学杂志》 20100131 易红，等 "几种注射用表面活性剂的质量标准及安全性概述" 第115-119页 1-4 第16卷, 第1期 * |
| 《中国实验方剂学杂志》 20100131 易红，等 "几种注射用表面活性剂的质量标准及安全性概述" 第115-119页 1-4 第16卷, 第1期 2 * |
| 《中国新药杂志》 20081231 张嘉，等 "聚山梨酯-80和泊洛沙姆188等4种增溶剂对小鼠的急性毒性" 第1491-1493页 1-4 第17卷, 第17期 2 * |
| 《医院制剂学》 19861231 张永恒，等 "丹参注射液" 人民卫生出版社 第155页 1-4 , * |
| 《医院制剂学》 19861231 张永恒，等 "丹参注射液" 人民卫生出版社 第155页 1-4 , 1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106111A (en) * | 2015-09-23 | 2015-12-02 | 成都艾比科生物科技有限公司 | Safe medicine composition for compound gastrodin injection and preparation method of safe medicine composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101897754B (en) | 2013-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101884658A (en) | Compound angelica medicament injection preparation containing polyethylene glycol 12-hydroxystearate and preparation method thereof | |
| CN101491678B (en) | Preparation method of injector using tween-80 as solubilizer | |
| CN103285135A (en) | Preparation technology for increasing clarity of poplar flower injection | |
| CN104367987A (en) | Astragalus mongholicus formulation for veterinary use and preparation method thereof | |
| CN106995369B (en) | It is a kind of using danshensu as the preparation method of the red sage root extract of object | |
| CN101897754B (en) | Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation | |
| CN100382784C (en) | Danhong drip pill prepared from salvia root and carthamus and its preparation method | |
| CN101884667A (en) | Xiangdan medicament injection preparation containing polyethylene glycol 12-hydroxystearate and preparation method thereof | |
| CN103417623A (en) | Salvia miltiorrhiza drug injection preparation containing polyethylene glycol 12 hydroxy stearic acid ester (Solutol HS 15, registered) and preparation method thereof | |
| CN103239505B (en) | Salvia miltiorrhiza medicine injection preparation containing polyethylene glycol-12-hydroxystearic acid and preparation method of salvia miltiorrhiza medicine injection preparation | |
| CN1679676A (en) | Six-component saf-flower drops and preparation thereof | |
| CN101897756B (en) | Preparation method of silver yellow medicinal preparation containing polyethylene glycol 12-hydroxy stearate | |
| CN100453073C (en) | Compound radical lobelia dripping pill and its preparing method | |
| CN100375616C (en) | Bone strengthening dripping pills with Premena fulva craib as raw material and method for preparing the same | |
| CN1301099C (en) | Earthworm drip pill and its preparation method | |
| CN101700385B (en) | Pharmaceutical composition medicinal liquor or tincture for curing white vein disease and preparation method thereof | |
| CN1315463C (en) | Guanxinning drip pill for treating heart disease and its preparation method | |
| CN1322854C (en) | Cold drop pills of mulberry and ginger in use for eliminating draft, clearing away heat, and preparing method | |
| CN100348169C (en) | Saussurea involucrata drop pill and its preparation method | |
| CN100406003C (en) | Dripping pills of abastard speedwell and its preparation process | |
| CN103432201A (en) | Honeysuckle and baical skullcap root pharmaceutical preparation containing polyethylene glycol 12-hydroxy stearate and preparation method thereof | |
| CN100364505C (en) | Fengshining drop pill for treating rheumatism and its preparation method | |
| CN100486598C (en) | Bupleurum root asarum herb dripping pill and its preparing method | |
| CN1315467C (en) | liver-clearing dropping pill for treating hepatitis and its preparing method | |
| CN1315464C (en) | Wild aconite drip pill for treating cancer pain and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: No. 3 high tech Zone Gaopeng road in Chengdu city of Sichuan Province in 610000 Applicant after: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Address before: High tech Zone Gaopeng road in Chengdu city of Sichuan province 610041 3 block A No. 9 Applicant before: Sichuan Sunnyhope Pharmaceutical Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation Effective date of registration: 20141120 Granted publication date: 20130814 Pledgee: China Huarong Asset Management Limited by Share Ltd Sichuan branch Pledgor: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Registration number: 2014510000035 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180209 Granted publication date: 20130814 Pledgee: China Huarong Asset Management Limited by Share Ltd Sichuan branch Pledgor: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Registration number: 2014510000035 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |